Skip to menu Skip to search Skip to content Skip to footer

Author:

A new infectious disease agency

By

In response to the Covid-19 pandemic, a new agency for research into emerging infectious diseases was created within INSERM In response to the Covid-19 pandemic, a new agency for research … Read more

Carmat markets its artificial heart

By

Carmat’s artificial heart, a veritable technological and medical breakthrough Carmat’s artificial heart, a veritable technological and medical breakthrough designed by Dr. Alain Carpentier, has been approved to go from prototype … Read more

Digital health as a driving force for the field in 2021

By

For this first Special Issue Newsletter of 2021, digital health is in the spotlight. Indeed, 2020 was a year full of challenges for all health stakeholders, but it was also synonymous with acceleration and changes for e-health companies in particular.

Invivox : Health – the necessary fast digitalisation offers new perspectives

By

Like the majority of players in the healthcare sector in 2020, Invivox had to digitalize itself through coercion. This is a development that has been envisaged but which has been greatly accelerated by the crisis, and which has nevertheless enabled us to become, in a few months, the leader in our field: that of the dissemination of knowledge among health professionals. But most importantly, this change provided new perspectives for 2021 and highlighted the usefulness of our sector. Our initial conviction is confirmed: the sharing of knowledge is the future of health.

Verso Healthcare, the only French group to have integrated all the components of e-health, continues its international development.

By

The independent French group, VERSO HEALTHCARE is a major player in the healthcare sector and has today many experts assigned in agencies throughout France as well as in Italy, Benelux and Switzerland. For more than 10 years, VERSO HEALTHCARE has supported healthcare professionals and institutions in the roll-out, optimization and availability of their technical platform from an economic, technical, organizational and regulatory point of view